HK1206990A1 - Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole - Google Patents
Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazoleInfo
- Publication number
- HK1206990A1 HK1206990A1 HK15107666.1A HK15107666A HK1206990A1 HK 1206990 A1 HK1206990 A1 HK 1206990A1 HK 15107666 A HK15107666 A HK 15107666A HK 1206990 A1 HK1206990 A1 HK 1206990A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- aripiprazole
- solid preparation
- oral solid
- producing
- producing oral
- Prior art date
Links
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title 2
- 229960004372 aripiprazole Drugs 0.000 title 2
- 239000007787 solid Substances 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013095725 | 2013-04-30 | ||
JP2013204546 | 2013-09-30 | ||
PCT/JP2014/061643 WO2014178334A1 (en) | 2013-04-30 | 2014-04-18 | Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1206990A1 true HK1206990A1 (en) | 2016-01-22 |
Family
ID=50897828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15107666.1A HK1206990A1 (en) | 2013-04-30 | 2015-08-08 | Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP3187173A1 (en) |
JP (1) | JP5931219B2 (en) |
KR (2) | KR101759017B1 (en) |
CN (1) | CN105246461B (en) |
AU (2) | AU2014260863A1 (en) |
CA (1) | CA2910665C (en) |
ES (1) | ES2625613T3 (en) |
HK (1) | HK1206990A1 (en) |
PH (1) | PH12015502435B1 (en) |
TW (2) | TWI624276B (en) |
WO (1) | WO2014178334A1 (en) |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2608788B2 (en) | 1988-10-31 | 1997-05-14 | 大塚製薬 株式会社 | Schizophrenia remedy |
CA2311734C (en) | 2000-04-12 | 2011-03-08 | Bristol-Myers Squibb Company | Flash-melt oral dosage formulation |
AR033485A1 (en) * | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | MEDICINAL SUBSTANCE OF ARIPIPRAZOL OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME |
ES2315721T5 (en) * | 2003-10-23 | 2012-08-24 | Otsuka Pharmaceutical Co., Ltd. | Formulation of sterile controlled-release injectable aripiprazole and procedure |
EP1933814A2 (en) * | 2005-09-15 | 2008-06-25 | Elan Pharma International Limited | Nanoparticulate aripiprazole formulations |
EP1919453A2 (en) * | 2005-12-22 | 2008-05-14 | Teva Pharmaceutical Industries Ltd | Processes for reducing particle size of aripiprazole |
PL1808164T3 (en) * | 2006-01-05 | 2009-06-30 | Teva Pharma | Wet granulation method for preparing pharmaceutical compositions of aripiprazole |
TR200604349A2 (en) * | 2006-08-15 | 2008-03-21 | NOBEL İLAÇ SANAYii VE TiCARET A.Ş. | Pharmaceutical compositions containing aripiprazole |
KR100924236B1 (en) * | 2009-06-23 | 2009-10-29 | 충남대학교산학협력단 | Methods and apparatus for preparing ultra-fine particles with narrow particle size distribution |
CN102106807B (en) * | 2009-12-29 | 2013-03-27 | 上海中西制药有限公司 | Method for preparing solid preparation and solid preparation |
US9241876B2 (en) * | 2011-06-27 | 2016-01-26 | Shanghai Zhongxi Pharmaceutical Corporation | Aripiprazole medicament formulation and preparation method therefor |
CN102850268B (en) * | 2011-06-27 | 2015-07-15 | 上海中西制药有限公司 | Aripiprazole I-type crystallite, aripiprazole solid preparation and preparation methods thereof |
TW201309651A (en) * | 2011-06-29 | 2013-03-01 | Otsuka Pharma Co Ltd | Method for producing fine particles of aripiprazole anhydride crystals B |
-
2014
- 2014-04-18 EP EP17156237.4A patent/EP3187173A1/en not_active Withdrawn
- 2014-04-18 KR KR1020157033739A patent/KR101759017B1/en active IP Right Grant
- 2014-04-18 CN CN201480030892.8A patent/CN105246461B/en not_active Expired - Fee Related
- 2014-04-18 ES ES14729061.3T patent/ES2625613T3/en active Active
- 2014-04-18 EP EP14729061.3A patent/EP2838513B1/en active Active
- 2014-04-18 CA CA2910665A patent/CA2910665C/en not_active Expired - Fee Related
- 2014-04-18 WO PCT/JP2014/061643 patent/WO2014178334A1/en active Application Filing
- 2014-04-18 AU AU2014260863A patent/AU2014260863A1/en not_active Abandoned
- 2014-04-18 JP JP2014553001A patent/JP5931219B2/en not_active Expired - Fee Related
- 2014-04-18 KR KR1020177011965A patent/KR20170052704A/en not_active Application Discontinuation
- 2014-04-28 TW TW103115151A patent/TWI624276B/en not_active IP Right Cessation
- 2014-04-28 TW TW106127320A patent/TW201740947A/en unknown
-
2015
- 2015-08-08 HK HK15107666.1A patent/HK1206990A1/en not_active IP Right Cessation
- 2015-10-22 PH PH12015502435A patent/PH12015502435B1/en unknown
-
2017
- 2017-06-30 AU AU2017204483A patent/AU2017204483B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
PH12015502435A1 (en) | 2016-02-22 |
KR101759017B1 (en) | 2017-07-17 |
CN105246461A (en) | 2016-01-13 |
WO2014178334A1 (en) | 2014-11-06 |
EP2838513A1 (en) | 2015-02-25 |
TW201740947A (en) | 2017-12-01 |
CA2910665A1 (en) | 2014-11-06 |
TW201521793A (en) | 2015-06-16 |
CA2910665C (en) | 2018-05-22 |
JP5931219B2 (en) | 2016-06-08 |
ES2625613T3 (en) | 2017-07-20 |
JP2015516942A (en) | 2015-06-18 |
KR20160003136A (en) | 2016-01-08 |
AU2014260863A2 (en) | 2015-12-17 |
EP3187173A1 (en) | 2017-07-05 |
PH12015502435B1 (en) | 2016-02-22 |
AU2014260863A1 (en) | 2015-11-05 |
AU2017204483A1 (en) | 2017-07-20 |
CN105246461B (en) | 2018-03-30 |
AU2017204483B2 (en) | 2019-04-04 |
EP2838513B1 (en) | 2017-04-05 |
KR20170052704A (en) | 2017-05-12 |
TWI624276B (en) | 2018-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1221720A1 (en) | Quinazoline derivative and preparation method therefor | |
EP2945678A4 (en) | Patient interface and method for making same | |
EP2945680A4 (en) | Patient interface and method for making same | |
EP3071276A4 (en) | Patient interface and method for making same | |
EP3006415B8 (en) | Method for producing nanocement and nanocement | |
EP3031353C0 (en) | Oral care system and method | |
SG11201500606UA (en) | Patient interface and method for making same | |
EP2967771A4 (en) | System and process for manufacturing of dentures | |
IL244285A0 (en) | Methods for preparing edible compositions and edible compositions produced thereby | |
SG11201505498YA (en) | Method for preparing polybutene | |
EP3006058A4 (en) | Blood filter and method for producing same | |
PL3040074T3 (en) | Injection preparation and method for producing same | |
EP2980084A4 (en) | Method for producing glycolide | |
HK1224221A1 (en) | Solid preparation comprising tofogliflozin and method for producing same | |
HK1202857A1 (en) | Benzodioxole derivative and preparation method and use thereof | |
EP2982843A4 (en) | Shield and method for producing shield | |
HK1206329A1 (en) | Phenol derivative, method of preparing same, and pharmaceutical application of same | |
EP2952519A4 (en) | Protopanoxadiol derivative, preparation method thereof and application thereof | |
IL239958A0 (en) | Chewable composition for oral administration and process for preparing thereof | |
PL3069610T3 (en) | Co-crystal and method for producing same | |
EP3051131A4 (en) | Compressor and method for producing compressor | |
EP2837624A4 (en) | 4-substituent-2-hydroxylmorpholine-3-one and preparation method thereof | |
HUP1300033A2 (en) | Improved process for producing pharmaceutical agent and intermediate | |
PL3062628T3 (en) | Improved chewing gums and methods for their preparation | |
EP2980083A4 (en) | Method for producing glycolide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210414 |